Michael P. Lisanti

Dr. Michael P. Lisanti

School of Science, Engineering and Environment, University of Salford, Salford M5 4WT, United Kingdom

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2016 in Nature Reviews Clinical Oncology
Verified
Journal Article
Closed access
UMUbaldo E. Martinez-Outschoorn
Ubaldo E. Martinez-Outschoorn
MPMaria Peiris-Pagés
Maria Peiris-Pagés
RPRichard G. Pestell
Richard G. Pestell
FSFederica Sotgia
Federica Sotgia
Michael P. LisantiMichael P. Lisanti
Michael P. Lisanti

1 October 2017 in Clinical Nutrition
Verified
Journal Article
Closed access
JAJann Arends
Jann Arends
VBV. Baracos
V. Baracos
HBH. Bertz
H. Bertz
FBF. Bozzetti
F. Bozzetti
PCPhilip Calder
Philip Calder
AWA. Weimann
A. Weimann

1 December 2012 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
ZYZuoren Yu
Zuoren Yu
TPTimothy G. Pestell
Timothy G. Pestell
Michael P. LisantiMichael P. Lisanti
Michael P. Lisanti
RPRichard G. Pestell
Richard G. Pestell

1 September 2010 in Cell Cycle
Verified
Journal Article
Open access
GBGloria Bonuccelli
Gloria Bonuccelli
ATAristotelis Tsirigos
Aristotelis Tsirigos
DWDiana Whitaker-Menezes
Diana Whitaker-Menezes
SPStephanos Pavlides
Stephanos Pavlides
RPRichard G. Pestell
Richard G. Pestell
Michael P. LisantiMichael P. Lisanti
Michael P. Lisanti
Previously, we proposed a new model for understanding the "Warburg effect" in tumor metabolism. In this scheme, cancer-associated fibroblasts undergo aerobic glycolysis and the resulting energy-ric...

22 January 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
RLRebecca Lamb
Rebecca Lamb
BOBela Ozsvari
Bela Ozsvari
CLCamilla L. Lisanti
Camilla L. Lisanti
HTHerbert B. Tanowitz
Herbert B. Tanowitz
AHAnthony Howell
Anthony Howell
Michael P. LisantiMichael P. Lisanti
Michael P. Lisanti
Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease

24 May 2016 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
MPMaria Peiris-Pagès
Maria Peiris-Pagès
UMUbaldo E. Martinez-Outschoorn
Ubaldo E. Martinez-Outschoorn
RPRichard G. Pestell
Richard G. Pestell
FSFederica Sotgia
Federica Sotgia
Michael P. LisantiMichael P. Lisanti
Michael P. Lisanti
Cancer is now viewed as a stem cell disease. There is still no consensus on the metabolic characteristics of cancer stem cells, with several studies indicating that they are mainly glycolytic and others pointing instead to mitochondrial metabolism as their principal source of energy. Cancer stem cells also seem to adapt their metabolism to microenvironmental changes by conveniently shifting energy production from one pathway to another, or by acquiring intermediate metabolic phenotypes. Determining the role of cancer stem cell metabolism in carcinogenesis has become a major focus in cancer research, and substantial efforts are conducted towards discovering clinical targets.